IL1F10 and colorectal carcinoma: While the precise underlying mechanism of IL-38 involvement in the progression of CRC remains to be determined, the observation from CRC patients invites speculation that colonic IL-38 protects the host from focal chronic inflammation and mucosal damage by counteracting with pro-inflammatory cytokines to balance homeostasis (14).